Email has been sent to with instructions on resetting your password.
Enroll in My Home to simplify finding a doctor and scheduling an appointment. Let's start!
By selecting "I Agree" or "Create Account" and clicking the box "I AGREE" below, you acknowledge and agree that you have read, understood and accepted the terms of service at the hyperlink below:
Legal and Privacy Notices
Awards & Recognition
Center for Faith Health Ministries
Community Benefit & Outreach
Dignity Health Arizona
Chandler Regional's History
Mission, Vision, Values
Principles of Behavior
GILBERT (July 24, 2018) – Dignity Health’s East Valley hospitals, Chandler Regional and Mercy Gilbert Medical Centers, have the ability to offer heart patients unprecedented access to approximately twenty groundbreaking medical studies.
Led by Nabil Dib, MD, the cardiovascular research program at Dignity Health in Arizona concentrates on investigating new drug therapies, new devices for heart procedures, and the use of biologics such as stem cells to help mend failing hearts. The primary goal of the work by Dr. Dib and his team is to provide additional potential treatment options to patients with coronary artery disease, heart failure, heart attack, and arrhythmia.
"The advancement of medicine has always relied on basic research and clinical studies,” explains Dr. Dib. “We are excited to be able to offer so many choices to our patients in the East Valley. Medicine is changing so quickly that we want to be sure that everyone is able to obtain the best possible treatments."
Dr. Dib hopes this work will open the door for more heart patients to participate in clinical studies at Dignity Health in the future. Backed by clinical research, Chandler Regional and Mercy Gilbert’s heart programs offer a wide-range services including prevention, diagnostic and cutting edge treatments.
"For the past 25 years, I have been conducting research and developing the newest investigational treatments for advanced cardiovascular disease. I can honestly say that there has never been a more exciting time in research than today. Our patients will have the chance to benefit," Dr. Dib says.